21h
TG Therapeutics, Inc.: TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial
Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 initiation dosing and a new single infusion on Day 1 only Safe ...
Kenneth Iwamasa injected the "Friends" star with a fatal dose of the hallucinogenic drug ketamine in October 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results